They were then evaluated for their anti-proliferative activity against carefully selected three cell lines namely: colorectal carcinoma HCT-116, hepatocellular carcinoma HepG-2 and breast MCF-7 cancer cell lines in which EGFR is expressed27. The gene discussed is EGFR; the disease is cancer.